Clinical trial Recruiting at 1 site Interventional Ages 1 Day to 28 Days

Isoleucine, leucine, valine and tryptophan needs in newborns on TPN

Official title: Isoleucine, Leucine, Valine and Tryptophan Requirements in Total Parenteral Nutrition (TPN) Fed Neonates

Run by The Hospital for Sick Children · NCT06372314 · Data updated 2026-11-12

This project will test how much isoleucine, leucine, valine, and tryptophan newborns who are fully fed by TPN need to support growth and normal metabolism.

More Stable Neonates trials

Quick facts

Study typeInterventional
Ages1 Day to 28 Days
SexAll
Enrollment80 (estimated)
SponsorThe Hospital for Sick Children
Academic / other
Locations1 site (Santa Maria)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedApril 2, 2026
Trial IDNCT06372314 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are medically stable neonates born at or after 28 weeks gestation, aged 28 days or less, who are receiving at least 90% of calories and protein via TPN and have normal lab results without infection or fever.

Probably not a fit

Babies who are mechanically ventilated or on significant respiratory support, small for gestational age, actively infected, receiving more than 10% of protein enterally, or on medications that alter amino acid metabolism are unlikely to be eligible or to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multi-center project in two hospitals in Brazil uses the carbon oxidation (indicator amino acid oxidation) method to define requirements for four essential amino acids in neonates receiving nearly all nutrition by TPN. Each enrolled baby will receive one or two intake levels of a target amino acid over two-day periods, with L-[1-13C]phenylalanine added as the indicator and L-[1-13C]Na bicarbonate used to measure CO2 production. Investigators will collect breath, urine, and small blood samples and analyze the indicator amino acid response using a biphasic linear mixed-effect model to identify the breakpoint or mean requirement for each amino acid. The team plans about 18–20 infants per amino acid and hypothesizes requirements may be substantially lower than current commercial formulations.

Why it matters

Potential benefit: If successful, the results could enable more precisely dosed neonatal TPN amino acid formulations that reduce excess intake and improve metabolic safety.

How similar studies have gone: The indicator amino acid oxidation technique is a validated method for defining amino acid needs in older populations and has been applied in infants before, but using it to set TPN-specific requirements for these four amino acids in fully TPN-fed neonates is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Stable preterm babies that are growing and fully TPN fed (at least 90% of calories and protein).
2. TPN providing adequate calories and protein as determined by attending physician and dietitian.
3. Babies born ≥ 28 weeks gestation,
4. ≤ 28 days chronological age at the time of the study,
5. Birth weight and length appropriate for gestational age,
6. Medically stable as determined by normal blood results and lack of a fever or infection,
7. At least 3 days after surgery, if the baby had a surgery

Exclusion Criteria:

1. Babies on mechanical ventilation, on low flow oxygen and CPAP.
2. Small for gestational age,
3. On medications known to affect protein and amino acid metabolism,
4. Documented infection, fever
5. Unstable medical condition
6. Receiving enteral feeding providing \> 10% of protein intake

Where it's running

  • Hospital de Caridade Dr. Astrogildo de Azevedo, and University Hospital of Santa Maria, Santa Maria, Brazil
    Santa Maria, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.